Aurinia Pharmaceuticals Inc. Increase Decrease Through Transfers And Other Changes Property Plant And Equipment
Aurinia Pharmaceuticals Inc. (AUPH) reported Increase Decrease Through Transfers And Other Changes Property Plant And Equipment of -$301.00 thousand for the 12-month period ending 2019-12-31, per its 40-F filed 2020-03-05.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment · last filed 2020-03-05
| Period end | Increase Decrease Through Transfers And Other Changes Property Plant And Equipment 12 month |
|---|---|
| 2019-12-31 | -$301.00K 40-F · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B |